1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Alsheikh-Ali A, Abourjaily HM, Stanek EJ, et al. Increases in HDL-cholesterol are the strongest predictors of risk reduction in lipid intervention trials. Circulation. 2004;110(17 suppl 3):III-813.
3. Jacobs DR, Jr, Meban IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32-47.
4. Gordon DJ, Probstfiel JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
5. Hu Fb, Willet WC, Li T, et al. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004;351:2694-2703.
6. Mensink RP, Zock PL, Kester A, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146-1155.
7. Pereira MA, Swain J, Goldfine AB, et al. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004;292:2482-2490.
8. Kokkinos PF, Holland JC, Pittaras AE, et al. Cardiorespiratory fitness and coronary heart disease risk factor association in women. J Am Coll Cardiol. 1995;26:358-364.
9. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002;347:716-725.
10. Kokkinos PE, Fernhall B. Physical activity and high density lipoprotein cholesterol levels: what is the relationship? Sports Med. 1999;28:307-314.
11. Van Der Gaag MS, Sterksma A, Schaafsma G, et al. Moderate alcohol consumption lowers risk factors for cardiovascular disease in postmenopausal women fed a controlled diet. Am J Clin Nutr. 2002;75:593-599.
12. Baer DJ, Judd JT, Clevidence BA, et al. Moderate alcohol consumption and changes in postprandial lipoproteins of premenopausal and postmenopausal women: a diet-controlled randomized intervention study. J Womens Health Gend Based Med. 2000;9:607-616.
13. Pins JJ, Keenan JM. Pantethine: a new option in managing dyslipidemia. J Am College Nutr. 2005 [in press].
14. Pins JJ, First S, Shamliyan T, Keenan J. Pantethine beneficially affects apolipoprotein A-1, apolipoprotein B, low-density lipoprotein particle size but not high-sensitivity C-reactive protein in a dyslipidemic population. Circulation. 2004;110(17 suppl 3):III-778.
15. Crouse JR, 3rd. New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug. Coron Artery Dis. 1996;7:321-326.
16. Retail pharmacy quote. Walgreen’s Pharmacy, Minneapolis, Minn. January 2005.
17. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
18. Hersberger M, von Eckardstein A. Low high-density lipoprotein cholesterol: physical background, clinical importance and drug treatment. Drugs. 2003;63:1907-1945.
19. Mosca L, Grundy SM, Judelson D, et al. Guide to preventive cardiology for women. AHA/ACC scientific statement, consensus panel statement. irculation. 1999;99:2480-2484.
20. Mosca L, Appel LJ, Benjamin EJ, et al. AHA Guidelines: evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693.
21. Clarkson T. Women’s Heart Health Symposium. Presented at the American Heart Association annual meeting, Nov 9, 2004, New Orleans.